Loading stock data…
Henry Schein, Inc. (HSIC)
$88.86-0.95 (-1.06%)
Market ClosedLast close Sep 8
Henry Schein, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Henry Schein, Inc. in the Healthcare sector is trading at $88.86 with a market capitalization of $10.0B. Wall Street consensus targets $98.19 (16 analysts), implying a +10.5% move over the next 12 months. The stock is currently near its 52-week high of $92.18, remaining 12.2% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +10.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $3.46B↑ | $3.37B↓ | $3.44B↑ | $3.34B↑ | $3.24B |
| Gross Profit | $1.10B↑ | $1.07B↑ | $1.06B↑ | $1.03B↑ | $1.02B |
| Operating Income | $200.00M↑ | $194.00M↑ | $186.00M↓ | $198.00M↑ | $174.00M |
| Net Income | $94.00M↓ | $107.00M↑ | $101.00M | $101.00M↑ | $86.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$10.00B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
26.17
Beta
Defensive asset. Lower volatility than the S&P 500.
0.81
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
12.77%
Volume
Today's trading volume
671,797
Recent News
Henry Schein (HSIC) is an Incredible Growth Stock: 3 Reasons Why
Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Henry Schein (HSIC) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Henry Schein (HSIC) Looks Modestly Undervalued, Is More Upside Still Available?
Henry Schein stock performance snapshot Henry Schein (HSIC) stock has drawn investor attention after recent share price moves, with the company reporting positive total returns over the past year and across multi year periods, alongside reported revenue and net income growth. At the latest share price of US$88.52, Henry Schein has given investors a 16.9% share price return over the past 90 days and a 29.4% total shareholder return over the past year. This suggests momentum has been building...
Growth Trajectory and Attractive Valuations Support Henry Schein’s (HSIC) Bullish Thesis
MD Sass, a boutique asset management firm, published its second-quarter investor update for its flagship, the “MD Sass Concentrated Value Strategy.” The letter can be downloaded here. In the first half of 2026, AI infrastructure stocks led the market, with the Russell 1000 Value increasing by 16.3%, outpacing the S&P 500 (10.2%) and Russell 1000 […]